322 related articles for article (PubMed ID: 26358798)
1. Anaplastic Thyroid Carcinoma, Version 2.2015.
Haddad RI; Lydiatt WM; Ball DW; Busaidy NL; Byrd D; Callender G; Dickson P; Duh QY; Ehya H; Haymart M; Hoh C; Hunt JP; Iagaru A; Kandeel F; Kopp P; Lamonica DM; McCaffrey JC; Moley JF; Parks L; Raeburn CD; Ridge JA; Ringel MD; Scheri RP; Shah JP; Smallridge RC; Sturgeon C; Wang TN; Wirth LJ; Hoffmann KG; Hughes M
J Natl Compr Canc Netw; 2015 Sep; 13(9):1140-50. PubMed ID: 26358798
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
Fan D; Ma J; Bell AC; Groen AH; Olsen KS; Lok BH; Leeman JE; Anderson E; Riaz N; McBride S; Ganly I; Shaha AR; Sherman EJ; Tsai CJ; Kang JJ; Lee NY
Cancer; 2020 Jan; 126(2):444-452. PubMed ID: 31593317
[TBL] [Abstract][Full Text] [Related]
3. Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical Trial.
Nomura H; Aoki D; Michimae H; Mizuno M; Nakai H; Arai M; Sasagawa M; Ushijima K; Sugiyama T; Saito M; Tokunaga H; Matoda M; Nakanishi T; Watanabe Y; Takahashi F; Saito T; Yaegashi N;
JAMA Oncol; 2019 Jun; 5(6):833-840. PubMed ID: 30896757
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for anaplastic thyroid cancer using docetaxel and cisplatin: report of eight cases.
Seto A; Sugitani I; Toda K; Kawabata K; Takahashi S; Saotome T
Surg Today; 2015 Feb; 45(2):221-6. PubMed ID: 25734195
[TBL] [Abstract][Full Text] [Related]
5. [Differential diagnosis and strategy for the treatment of anaplastic thyroid carcinoma].
Suzuki S
Nihon Rinsho; 2007 Nov; 65(11):2079-86. PubMed ID: 18018574
[TBL] [Abstract][Full Text] [Related]
6. Long term survival with adjuvant carboplatin, paclitaxel, and radiation therapy in anaplastic thyroid cancer.
Haddad R; Mahadevan A; Posner MR; Sullivan C
Am J Clin Oncol; 2005 Feb; 28(1):104. PubMed ID: 15685044
[No Abstract] [Full Text] [Related]
7. Diagnosis and Management of Anaplastic Thyroid Cancer.
Chintakuntlawar AV; Foote RL; Kasperbauer JL; Bible KC
Endocrinol Metab Clin North Am; 2019 Mar; 48(1):269-284. PubMed ID: 30717908
[TBL] [Abstract][Full Text] [Related]
8. A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer.
Chintakuntlawar AV; Yin J; Foote RL; Kasperbauer JL; Rivera M; Asmus E; Garces NI; Janus JR; Liu M; Ma DJ; Moore EJ; Morris JC; Neben-Wittich M; Price DL; Price KA; Ryder M; Van Abel KM; Hilger C; Samb E; Bible KC
Thyroid; 2019 Nov; 29(11):1615-1622. PubMed ID: 31595822
[No Abstract] [Full Text] [Related]
9. Complete response to weekly carboplatin-docetaxel chemotherapy in a 91-year-old woman with anaplastic thyroid cancer.
Koussis H; Giorgi CA; Di Liso E; Carlucci MC; Fassina A; Marioni G; Conte PF
Am J Otolaryngol; 2015; 36(2):268-72. PubMed ID: 25681954
[TBL] [Abstract][Full Text] [Related]
10. Thyroid Cancer: Risk-Stratified Management and Individualized Therapy.
Raue F; Frank-Raue K
Clin Cancer Res; 2016 Oct; 22(20):5012-5021. PubMed ID: 27742787
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies.
Molinaro E; Romei C; Biagini A; Sabini E; Agate L; Mazzeo S; Materazzi G; Sellari-Franceschini S; Ribechini A; Torregrossa L; Basolo F; Vitti P; Elisei R
Nat Rev Endocrinol; 2017 Nov; 13(11):644-660. PubMed ID: 28707679
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic thyroid cancer: Prognostic factors, patterns of care, and overall survival.
Glaser SM; Mandish SF; Gill BS; Balasubramani GK; Clump DA; Beriwal S
Head Neck; 2016 Apr; 38 Suppl 1():E2083-90. PubMed ID: 26894506
[TBL] [Abstract][Full Text] [Related]
13. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†.
Filetti S; Durante C; Hartl D; Leboulleux S; Locati LD; Newbold K; Papotti MG; Berruti A;
Ann Oncol; 2019 Dec; 30(12):1856-1883. PubMed ID: 31549998
[No Abstract] [Full Text] [Related]
14. Thyroid Carcinoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Haddad RI; Bischoff L; Ball D; Bernet V; Blomain E; Busaidy NL; Campbell M; Dickson P; Duh QY; Ehya H; Goldner WS; Guo T; Haymart M; Holt S; Hunt JP; Iagaru A; Kandeel F; Lamonica DM; Mandel S; Markovina S; McIver B; Raeburn CD; Rezaee R; Ridge JA; Roth MY; Scheri RP; Shah JP; Sipos JA; Sippel R; Sturgeon C; Wang TN; Wirth LJ; Wong RJ; Yeh M; Cassara CJ; Darlow S
J Natl Compr Canc Netw; 2022 Aug; 20(8):925-951. PubMed ID: 35948029
[TBL] [Abstract][Full Text] [Related]
15. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
Haddad RI; Nasr C; Bischoff L; Busaidy NL; Byrd D; Callender G; Dickson P; Duh QY; Ehya H; Goldner W; Haymart M; Hoh C; Hunt JP; Iagaru A; Kandeel F; Kopp P; Lamonica DM; McIver B; Raeburn CD; Ridge JA; Ringel MD; Scheri RP; Shah JP; Sippel R; Smallridge RC; Sturgeon C; Wang TN; Wirth LJ; Wong RJ; Johnson-Chilla A; Hoffmann KG; Gurski LA
J Natl Compr Canc Netw; 2018 Dec; 16(12):1429-1440. PubMed ID: 30545990
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic Thyroid Cancer: New Horizons and Challenges.
Maniakas A; Zafereo M; Cabanillas ME
Endocrinol Metab Clin North Am; 2022 Jun; 51(2):391-401. PubMed ID: 35662448
[TBL] [Abstract][Full Text] [Related]
17. Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.
Chu Q; Vincent M; Logan D; Mackay JA; Evans WK;
Lung Cancer; 2005 Dec; 50(3):355-74. PubMed ID: 16139391
[TBL] [Abstract][Full Text] [Related]
18. Anaplastic thyroid cancer: a case report of a long term survival patient and review of literature data.
Ursino S; Fiorica F; Stefanelli A; Pedriali M; Colosimo C; Cocuzza P; Mazzotti V; Taibi R; Cartei F; Greco C
Eur Rev Med Pharmacol Sci; 2014; 18(9):1368-72. PubMed ID: 24867515
[TBL] [Abstract][Full Text] [Related]
19. Anaplastic thyroid cancer: the addition of systemic chemotherapy to radiotherapy led to an observed improvement in survival--a single centre experience and review of the literature.
Lowe NM; Loughran S; Slevin NJ; Yap BK
ScientificWorldJournal; 2014; 2014():674583. PubMed ID: 25184150
[TBL] [Abstract][Full Text] [Related]
20. Low-intermediate dose of lenvatinib in anaplastic thyroid cancer is highly effective and safe.
Barbaro D; Lapi P; Viacava P; Torregrossa L
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
